Respiratory Infections Portfolio
Detection of highly transmissible respiratory pathogens
The efficiency and versatility offered by the BD MAX™ System and the Respiratory portfolio facilitate high volume molecular testing for rapid diagnosis and treatment.
Global pandemics occur when new strains occur of known respiratory viruses.
The BD MAX™ System is a single platform capable
of running BD and partner developed assays
as well as laboratory-developed tests